Document Detail

Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome.
MedLine Citation:
PMID:  11305056     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We assessed the clinical outcome of self-expanding Wallstent endovascular prosthesis in the treatment of superior vena cava syndrome due to malignant tumors. METHODS: Eleven patients with malignant superior vena cava syndrome were treated by percutaneous implantation of the self-expanding Wallstent endovascular prosthesis across the stricture site. Patency was defined by the absence of symptoms and signs of superior vena cava syndrome. RESULTS: Ten of the 11 experienced complete symptomatic relief within 3 days of stent implantation. The remaining 1 did not benefit, and required a second procedure, dying of heart failure 5 days after stent implantation. Ten patients remain symptomatically free of superior vena cava syndrome to date or until death in follow-up lasting 17 to 227 days. CONCLUSION: Implantation of the self-expanding Wallstent endovascular prosthesis for malignant superior vena cava syndrome provides rapid symptomatic relief and improves the patient's quality of life.
S Sasano; T Onuki; M Mae; K Oyama; M Sakuraba; S Nitta
Related Documents :
15741446 - Implantation of a pleurovenous shunt for massive chylothorax in a patient with yellow n...
15884466 - Papillary carcinoma of thyroid presenting as posterior mediastinal mass with superior v...
3942126 - Budd-chiari syndrome in sarcoidosis.
19111036 - Scimitar syndrome.
11237546 - Does early repolarization in the athlete have analogies with the brugada syndrome?
25120946 - Mirror movements identified in patients with moebius syndrome.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai zasshi     Volume:  49     ISSN:  1344-4964     ISO Abbreviation:  Jpn. J. Thorac. Cardiovasc. Surg.     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-04-17     Completed Date:  2001-05-31     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100884261     Medline TA:  Jpn J Thorac Cardiovasc Surg     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  165-70     Citation Subset:  IM    
Department of Surgery I, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anticoagulants / administration & dosage
Heparin / administration & dosage
Middle Aged
Neoplasms / complications
Superior Vena Cava Syndrome / drug therapy,  etiology,  therapy*
Treatment Outcome
Reg. No./Substance:
0/Anticoagulants; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bilateral internal thoracic artery T grafting for coronary artery revascularization. Angiographic as...
Next Document:  Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure.